Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. nuclear medicine
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Nuclear Medicine Articles & Analysis

30 news found

Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100) to Improve Heart Failure Outcomes & Reduce Costs

Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100) to Improve Heart Failure Outcomes & Reduce Costs

Jefferies, M.D., MPH, University of Tennessee Health Science Center, Memphis, Tennessee, Timothy Manzone, M.D. Former Section Chief Nuclear Medicine, ChristianaCare, Newark, Delaware, and James Kreiner, MHA, Director Cardiovascular Operations, Prisma Richland, Columbia, South Carolina. ...

ByDaxor Corporation


ITM: Isotope Production System Begins Commercial Production of Cancer-Fighting Lutetium-177

ITM: Isotope Production System Begins Commercial Production of Cancer-Fighting Lutetium-177

This milestone was achieved following completion of final commissioning and regulatory approval from the Canadian Nuclear Safety Commission and is the culmination of a multi-year project to install a novel Isotope Production System (IPS) in Bruce Power’s Unit 7. ...

ByITM Isotope Technologies Munich SE


CTT to Present Data on Prostate Cancer Therapy Candidates at Upcoming Conferences

CTT to Present Data on Prostate Cancer Therapy Candidates at Upcoming Conferences

The meetings featuring CTT presentations include the American Society of Clinical Oncologists (ASCO) 2017 Annual Meeting June 2-6 in Chicago; the Society of Nuclear Medicine and Medical Imaging (SNMMI) 2017 Annual Meeting June 10-14 in Denver; and the 253rd American Chemical Society (ACS) National Meeting and Exposition, which was held April 2-6 in San Francisco. ...

ByCancer Targeted Technology


Prof. Krestin Joins Fluidda’S Board of Directors

Prof. Krestin Joins Fluidda’S Board of Directors

In 1997 he moved to Erasmus MC in Rotterdam, Netherlands where he was the Professor and Chairman of the Department of Radiology & Nuclear Medicine until his retirement end of 2021. Dr. Krestin is (co-)author of over 450 original articles, (co) author of more than 101 book chapters, and editor of 15 books. ...

ByFluidda


Betaglue technologies strengthen its expertise in strategic areas with four new managers

Betaglue technologies strengthen its expertise in strategic areas with four new managers

The three managers join the company from Novartis, after having worked at Advanced Accelerator Applications (AAA), a company that has pioneered the nuclear medicine revolution, following its recent €3.9 billion acquisition. ...

ByBetaGlue Technologies SpA


BetaGlue has enrolled the first patient treated with BAT-90 in its First-in-Human trials, taking radiotherapy inside solid tumours

BetaGlue has enrolled the first patient treated with BAT-90 in its First-in-Human trials, taking radiotherapy inside solid tumours

Indeed, BAT-90 is atherapeutic nuclear medicinesolution that is extremelyprecise(it only targets the tumour area),personalised(calibrated to the patient’sclinical situation),rapid(a single injection reaching full polymerisation in just a fewminutes) andsafe(the radiation energy is released where needed, avoiding exposure ofsurrounding tissues and organs and thus minimizing ...

ByBetaGlue Technologies SpA


Betaglue technologies: closing of a eur 10 million financing round

Betaglue technologies: closing of a eur 10 million financing round

Benefits BAT-90 is a therapeutic nuclear medicine solution that is extremely precise (it only targets the tumour area), personalised (calibrated to the patient's clinical situation), rapid (a single injection reaching full polymerisation in just a few minutes) and safe (the radiation energy is released where needed, avoiding exposure of surrounding tissues and ...

ByBetaGlue Technologies SpA


FAPI featured in accolades at annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting

FAPI featured in accolades at annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting

Congratulations to investigators at Hannover School of Medicine and Heidelberg University Hospital for receiving the 2022 SNMMI Image of the Year Award and JNM Editors’ Choice Award for Overall Best Article in 2021, respectively. ...

BySOFIE


Betaglue takes radiotherapy inside solid tumours: first patient treated

Betaglue takes radiotherapy inside solid tumours: first patient treated

Antonino Amato, said: "The confirmation in this first patient of the previous findings from the pre-clinical studies with BAT-90 opens up tremendous perspectives for therapeutic nuclear medicine in oncology, which will hopefully lead to improved outcomes and better quality of life for patients affected by several types of cancer. The targeted and localised BAT-90 ...

ByBetaGlue Technologies SpA


Blue Earth Diagnostics Appoints Dr. David E. Gauden as Chief Executive Officer and Dr. Eugene J. Teoh as Chief Medical Officer

Blue Earth Diagnostics Appoints Dr. David E. Gauden as Chief Executive Officer and Dr. Eugene J. Teoh as Chief Medical Officer

Teoh obtained his medical degree from Imperial College School of Medicine, in London, UK, and completed his initial medical training in Oxford and London. This was followed by specialist training in radiology at Oxford, leading to board-certification in radiology with subspecialization in diagnostic nuclear medicine. Dr. Teoh is a member of the ...

ByBlue Earth Diagnostics


Positron Corporation Retains FDA Consulting Firm in Preparation for 510K New Device Application

Positron Corporation Retains FDA Consulting Firm in Preparation for 510K New Device Application

Niagara Falls, NY – February 17, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is pleased to announce today that the Company has retained Medical Device Academy ”MDA”) as its consultant for the ...

ByPositron Corporation


Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems

Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems

Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems for the Development and Distribution of Positron’s State of the Art PET/CT System in North America Niagara Falls, NY – January 18, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging ...

ByPositron Corporation


Phase II study demonstrates prognostic value of uPAR-PET in head and neck cancer patients

Phase II study demonstrates prognostic value of uPAR-PET in head and neck cancer patients

Results from an investigator-initiated phase II study performed by researchers at Rigshospitalet and using the uTRACE[®] technology have now been published online ahead of print in the prestigious Journal of Nuclear Medicine. The abstract of the article is freely available here (https://pubmed.ncbi.nlm.nih.gov/34857658/). ...

ByCurasight


Positron Files Financial Reports & Announces Pink Current OTC Reporting & Disclosures Status

Positron Files Financial Reports & Announces Pink Current OTC Reporting & Disclosures Status

Positron Files all Financial Reports and Announces the Company is Current with its OTC Reporting & Disclosures Niagara Falls, NY – October 29, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron Emission Tomography ...

ByPositron Corporation


Lightpoint Medical to Present Positive Clinical Trial Data for SENSEI Miniature Gamma Probe in Prostate Cancer Surgery

Lightpoint Medical to Present Positive Clinical Trial Data for SENSEI Miniature Gamma Probe in Prostate Cancer Surgery

The trial results will be presented today at the Annual Congress of the European Association of Nuclear Medicine. The clinical trial results demonstrate the ease of use and performance of SENSEI in prostate cancer surgery and signal potential application in other surgical procedures across major cancer types. ...

ByLightpoint Medical, Ltd


Cairn Diagnostics Delivers Virtual Administration of its Novel 13C-Spirulina Gastric Emptying Breath Test

Cairn Diagnostics Delivers Virtual Administration of its Novel 13C-Spirulina Gastric Emptying Breath Test

Cairn Diagnostics, an innovative leader in providing cutting-edge breath tests intended for routine use in diagnostic medicine, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of the Company’s 13C-Spirulina Gastric Emptying Breath Test (GEBT) to now include “at home” administration under virtual supervision of Cairn ...

ByCairn Diagnostics


Christie Med Announces New Authorized Partner in Al Zahrawi for UAE Distribution of VeinViewer

Christie Med Announces New Authorized Partner in Al Zahrawi for UAE Distribution of VeinViewer

Al Zahrawi Medical is a healthcare focused company specializing in medical, surgical, diagnostic and analytical lab, and nuclear medicine supplies with a presence throughout the region. Al Zahrawi provides top quality products, services, and support to customers in the medical and laboratory industries that create rewarding customer experiences that build long ...

ByChristie Medical Holdings, Inc.


HistoSonics Announces First Patient Treated in European Clinical Trial

HistoSonics Announces First Patient Treated in European Clinical Trial

Maciej Pech, Interventional Radiologist, Director of University Clinic for Radiology and Nuclear Medicine and Principal Investigator of the #HOPE4LIVER site in Magdeburg, Germany. ...

ByHistoSonics


Finally, Digital Myocardial Perfusion Imaging That’s Within Reach: SPECT CZT Technology Just Became More Accessible

Finally, Digital Myocardial Perfusion Imaging That’s Within Reach: SPECT CZT Technology Just Became More Accessible

“It is a significant addition to our technology-leading portfolio of SPECT digital imaging systems, built to bring a paradigm shift in Nuclear Medicine technology, scanner design and performance”. ...

BySpectrum Dynamics Medical


BetaGlue Technologies announces new Board of Directors

BetaGlue Technologies announces new Board of Directors

Luigi Costa brings over 25 years of operational and leadership experience in the global biopharma and Nuclear Medicine sector. He was CEO of Nordic Nanovector and led one of the largest European biotech IPOs. ...

ByBetaGlue Technologies SpA

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT